South San Francisco, CA, United States of America

Peyman Akbari

This inventor holds 2 USPTO granted patents. Top assignee: Xbiome Inc.. Active years: 2024-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Peyman Akbari. Retrieved from https://idiyas.com/inventor/peyman-akbari

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 50.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2024-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Peyman Akbari: Pioneering Bacterial Strains for Medical Advancements

Introduction: Peyman Akbari, an accomplished inventor based in South San Francisco, CA, has made significant strides in the field of biotechnology. With a focus on bacterial compositions, his work contributes to innovative solutions in medical treatments.

Latest Patents: Peyman Akbari holds a patent for "Compositions comprising bacterial species and methods related thereto." This patent includes bacterial strains of the genus sp. P152-H6d and compositions that utilize these strains. The methods disclosed within this patent are aimed at preventing or treating various disorders, including inflammatory, gastrointestinal, metabolic disorders, and dysbiosis.

Career Highlights: Akbari is currently affiliated with Xbiome Inc., where he applies his expertise to the development of advanced biotechnological solutions. His research is instrumental in exploring new treatments that harness the power of beneficial bacteria.

Collaborations: During his career, Peyman Akbari has had the opportunity to work alongside notable colleagues such as Ali Akin and Rounak Feigelman. These collaborations have fostered a creative environment that drives innovation and enhances the potential for impactful discoveries.

Conclusion: Peyman Akbari's contributions to the field of biotechnology are marked by his innovative patent and collaborative spirit. As research progresses at Xbiome Inc., his work promises to lead to significant advancements in the prevention and treatment of various health disorders, enhancing the understanding and utilization of bacterial strains in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…